Abstract
Approximately 10% of infants screened for ROP require treatment. Current treatment options include Panretinal Laser Photocoagulation or Intravitreal antiVEGF. Our institution provides treatment of ROP for a very large geographic region, making the travel burden for some patients a large barrier to care access. Our aim is to compare the follow-up and travel burden between patients with ROP treated with laser and those treated with intravitreal antiVEGF at our institution.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
